Cyclosporin A-Derivative 2 is a novel derivative from cyclosporin A. Cyclosporin A is an immunosuppressive agent which can bind to the cyclophilin and inhibit calcineurin.
Cyclosporin A-Derivative 2 is a chemically modified analog of the well-known cyclic peptide Cyclosporin A, designed to retain the core cyclic undecapeptide structure while introducing targeted modifications to its amino acid residues or side chains. As a member of the peptide compound family, this derivative offers unique biochemical properties that distinguish it from its parent molecule, providing a valuable tool for advanced research in peptide function, protein-protein interactions, and cellular signaling pathways. Its structural alterations can modulate binding affinities and biological activities, making it a significant asset for studies aiming to elucidate structure-activity relationships and optimize peptide-based molecular probes.
Immunophilin research: Cyclosporin A derivatives are widely recognized for their ability to bind cyclophilins, a family of immunophilin proteins involved in protein folding and intracellular signaling. By employing this derivative in binding assays or co-crystallization experiments, researchers can investigate the effects of specific molecular modifications on cyclophilin interaction. Such studies are essential for dissecting the molecular mechanisms underlying immunophilin function and for identifying new avenues to modulate protein-protein interactions in cellular systems.
Peptide structure-activity relationship studies: The introduction of defined chemical modifications in Cyclosporin A-Derivative 2 enables systematic exploration of how structural changes affect peptide bioactivity, stability, and target specificity. Researchers utilize this compound in comparative assays alongside the parent molecule to map critical functional groups responsible for biological activity. These investigations provide foundational data for the rational design of next-generation cyclic peptides with improved selectivity or altered pharmacological profiles for research use.
Signal transduction analysis: Cyclic peptides like this derivative are instrumental in probing cellular signaling pathways, particularly those involving calcineurin and related phosphatases. By incorporating the derivative into cell-based or in vitro assays, scientists can delineate the impact of peptide modifications on signaling cascade modulation, protein dephosphorylation, and downstream gene expression. Such experiments contribute to a deeper understanding of signal transduction mechanisms and the potential regulatory roles of peptide-based modulators.
Peptide stability and metabolic profiling: Chemical modifications present in Cyclosporin A-Derivative 2 can significantly influence its metabolic stability, proteolytic resistance, and cellular uptake. Researchers employ this compound in enzymatic degradation assays and metabolic profiling studies to assess its stability relative to unmodified Cyclosporin A. These insights are crucial for optimizing peptide scaffolds intended for use in biochemical assays or as molecular tools in complex biological environments.
Chemical biology tool development: The unique properties of this derivative, including altered binding characteristics and enhanced stability, make it a valuable scaffold for the development of chemical probes and affinity reagents. Scientists can functionalize the molecule further or use it as a template for conjugation to reporter groups, facilitating the study of protein complexes, localization, and dynamic cellular processes. Its versatility supports a wide range of chemical biology applications, from target identification to mechanistic investigations in advanced research settings.
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More